Literature DB >> 15690641

Megakaryoblastic disorders in children.

Robert B Lorsbach1.   

Abstract

Acute leukemia is the most common neoplasm in children, of which approximately one fourth of cases are acute myeloid leukemia. To a large extent, the clinicopathologic spectrum of acute myeloid leukemia seen in the pediatric age group is similar to that in adults. However, megakaryoblastic proliferations, including transient myeloproliferative disorder and acute megakaryoblastic leukemia, occur exclusively or predominantly in children. Although the clinical and pathologic features of these disorders have been well characterized, until recently their pathogenetic mechanisms have remained poorly understood. Recent advances have provided important insight into the pathogenesis of these disorders, and they provide a molecular basis for a clinically meaningful classification of primary megakaryoblastic disorders in the pediatric age group.

Entities:  

Mesh:

Year:  2004        PMID: 15690641     DOI: 10.1309/Y57UGTE36PGQ2NV6

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  3 in total

1.  Megakaryoblastic leukemia presenting as pancytopenia and extensive myelofibrosis in a child diagnosed by myeloid markers and CD 31.

Authors:  Urmila Majhi; Kanchan Murhekar; Shirley Sundersingh; K R Rajalekshmi
Journal:  Indian J Med Paediatr Oncol       Date:  2012-01

2.  Immunomodulatory drugs downregulate IKZF1 leading to expansion of hematopoietic progenitors with concomitant block of megakaryocytic maturation.

Authors:  Ailing Liu; Shirong Li; Vera Donnenberg; Jing Fu; Susanne M Gollin; Huihui Ma; Caisheng Lu; Donna B Stolz; Markus Y Mapara; Sara A Monaghan; Suzanne Lentzsch
Journal:  Haematologica       Date:  2018-06-28       Impact factor: 9.941

3.  Immunophenotypic Analysis of Acute Megakaryoblastic Leukemia: A EuroFlow Study.

Authors:  Nienke Brouwer; Sergio Matarraz; Stefan Nierkens; Mattias Hofmans; Michaela Nováková; Elaine Sobral da Costa; Paula Fernandez; Anne E Bras; Fabiana Vieira de Mello; Ester Mejstrikova; Jan Philippé; Georgiana Emilia Grigore; Carlos E Pedreira; Jacques J M van Dongen; Alberto Orfao; Vincent H J van der Velden
Journal:  Cancers (Basel)       Date:  2022-03-21       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.